SEMA7A and neoplasm: In vivo, SEMA7A knockdown in MCF10DCIS cells led to significant decreases in tumour growth, the lower expression of invasive markers such as p63 and vimentin and the increased expression of E-cadherin, which suggest that the knockdown of SEMA7A may reverse EMT.